Healthcare -
Biotechnology - NASDAQ - US
$ 5.25
8.25 %
$ 111 M
Market Cap
-0.96
P/E
ENTA - TOTAL EQUITY
Total Equity ENTA - Enanta Pharmaceuticals, Inc.
129 M
LAST VALUE
-36.69%
2 YEAR CAGR
-22.56%
5 YEAR CAGR
-1.42%
10 YEAR CAGR